The effectiveness of kinesiotaping in treating chronic lateral epicondylitis: a randomized, sham-controlled, single-blind study

Table 3 Comparison of evaluation parameters between groups and within-groups

Variable	KT Group (n = 21)			Sham Group (n = 21)			Between-group analysis (p*)
PRTEE-pain
W0	35.0 (30–46)			39.0 (29–41)			0.850
W3	14.0 (7–19)			24.0 (19–31)			< 0.001
W7	13.9 (5–21)			25.0 (21–32)			< 0.001
P^a	< 0.001			<0.001
	W0-3	W0-7	W3-7	W0-3	W0-7	W3-7
Z	4.02	4.02	0.12	3.54	3.21	0.91
p^b	< 0.001	< 0.001	0.906	< 0.001	< 0.001	0.364
r	0.62	0.62	0.02	0.55	0.50	0.02
PRTEE-function
W0	34.0 (24–43)			34.0 (28–41)			0.890
W3	13.0 (8–16)			23.0 (20–28)			< 0.001
W7	13.0 (5–19)			21.5 (18–34)			< 0.001
P^a	< 0.001			0,118
	W0-3	W0-7	W3-7	W0-3	W0-7	W3-7
Z	4.02	4.02	0.54	2.82	2.28	0.26
p^b	< 0.001	< 0.001	0.589	0.005	0.023	0.793
r	0.62	0.62	0.08	0.44	0.50	0.04
PRTEE-total
W0	68.5 (55–84)			73.0 (58–83)			0.890
W3	26.5 (14–35)			46.5 (38–58)			< 0.001
W7	27.5 (10–38)			46.0 (39–65)			< 0.001
P^a	< 0.001			0.047
	W0-3	W0-7	W3-7	W0-3	W0-7	W3-7
Z	4.016	4.015	0.313	3.32	2.798	0.63
p^b	< 0.001	< 0.001	0.755	< 0.001	0.005	0.526
r	0.62	0.62	0.05	0.51	0.43	0.09
DASH Total
W0	94.0 (70–106)			89.0 (74–109)			0.811
W3	40.0 (35–64)			66.0 (60–87)			0.002
W7	41.0 (31–55)			66.0 (57–86)			< 0.001
P^a	< 0.001			< 0.001
	W0-3	W0-7	W3-7	W0-3	W0-7	W3-7
Z	3.79	3.98	0.39	2.91	3.04	0.94
p^b	< 0.001	< 0.001	0.700	0.004	0.002	0.345
r	0.58	0.61	0.06	0.45	0.47	0.15

r: Effect size * Mann-Whitney U test; P^a Friedman test; ^b Wilcoxon Signed-Ranks test; W0-3, W0-7, W3-7: Pre-post treatment differences; Median (1st quartile–3rd quartile) for non-normal distribution values were used. Adjusted p-values were considered significant based on Bonferroni correction
W0: Baseline assessment (pre-treatment)
W3: Assessment immediately after treatment completion (week three)
W7: Assessment 4 weeks after treatment completion (week seven)

ISSN: 1749-799X